Viral Vector Manufacturing Market Highlights:
It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period from 2018 to 2023. Gene therapy is one of the preferred treatment options for most chronic diseases, involving insertion of a functional copy of a gene into a defective cell.
Competitive Key Players:
Some of the key players in the global viral vector manufacturing market are FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., and Kaneka Eurogentec S.A.
Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/6890
Segmentation:
Global Viral Vector Manufacturing Market, by Type
- Retroviral Vectors
- Lentiviral Vectors
- Gamma-Retroviral Vectors
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
- Other Viral Vectors
Global Viral Vector Manufacturing Market, by Disease
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
Global Viral Vector Manufacturing Market, by Application
- Gene Therapy
- Vaccinology
Global Viral Vector Manufacturing Market, by End-user
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Others
Browse Complete Report Details at https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Viral Vector Manufacturing Market, By Type
Chapter 7. Global Viral Vector Manufacturing Market, By Disease
Chapter 8. Global Viral Vector Manufacturing Market, By Application
Chapter 9. Global Viral Vector Manufacturing Market, By End-User
Chapter 10. Global Viral Vector Manufacturing Market, By Region
Chapter 11. Company Landscape
Chapter 12. Company Profiles
Chapter 13 MRFR Conclusion
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Viral Vector Manufacturing Market Synopsis, 2018–2023
Table 2 Global Viral Vector Manufacturing Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Viral Vector Manufacturing Market, By Type, 2018–2023 (USD Million)
Table 4 Global Viral Vector Manufacturing Market, By Disease, 2018–2023 (USD Million)
Table 5 Global Viral Vector Manufacturing Market, By Application, 2018–2023 (USD Million)
Table 6 Global Viral Vector Manufacturing Market, By End-User, 2018–2023 (USD Million)
Table 7 Global Viral Vector Manufacturing Market, By Region, 2018–2023(USD Million)
…Continue
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Viral Vector Manufacturing Market
Figure 3 Segmentation Market Dynamics For Global Viral Vector Manufacturing Market
Figure 4 Global Viral Vector Manufacturing Market Share, By Type, 2017 (%)
Figure 5 Global Viral Vector Manufacturing Market Share, By Disease, 2017 (%)
Figure 6 Global Viral Vector Manufacturing Market Share, By Application, 2017 (%)
Figure 7 Global Viral Vector Manufacturing Market Share, By End-User, 2017 (%)
Figure 8 Global Viral Vector Manufacturing Market Share, By Region, 2017 (%)
…Continue
Regional Analysis:
Americas is projected to dominate the global viral vector manufacturing market due to a well-developed healthcare sector and rising prevalence of autoimmune and chronic diseases. According to a study published by Partnership to Fight Chronic Disease (PFCD) in 2016, 191 million people in America had at least 1 chronic disease, whereas 75 million had 2 or more chronic diseases in the year 2015. Europe is expected to hold the second largest position in the global viral vector manufacturing market. The market growth in this region is attributed to the availability of funds for research and increasing healthcare expenditure. According to the European Commission, in 2016 the total expenditure of the governments of the European Union on health amounted to 7.1% of GDP. Also, according to National Institute of Health Funding (NIHR) in the year 2016, a funding of Euro 928 million was announced for new NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities (CRF) for 5 years starting from April 2017.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies. On the other hand, the Middle East and Africa has the least share of the market.
Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6890
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com